Outlook Therapeutics (OTLK) Assets Growth (3y) (2018 - 2026)
Outlook Therapeutics (OTLK) Assets Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Outlook Therapeutics |
86.15 Mn |
78.40 Mn |
-21,888.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-26.00% |
| Dec 31, 2025 |
-33.74% |
| Sep 30, 2025 |
-13.31% |
| Jun 30, 2025 |
-16.59% |
| Mar 31, 2025 |
-34.44% |
| Dec 31, 2024 |
-39.99% |
| Sep 30, 2024 |
8.11% |
| Jun 30, 2024 |
12.72% |
| Mar 31, 2024 |
9.38% |
| Dec 31, 2023 |
20.10% |
| Sep 30, 2023 |
17.85% |
| Jun 30, 2023 |
13.69% |
| Mar 31, 2023 |
60.08% |
| Dec 31, 2022 |
81.86% |
| Sep 30, 2022 |
18.52% |
| Jun 30, 2022 |
5.13% |
| Mar 31, 2022 |
57.96% |
| Dec 31, 2021 |
61.41% |
| Sep 30, 2021 |
0.78% |
| Jun 30, 2021 |
-1.19% |
